BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Interviews
  • Products
  • Submit PR
  • Home
  • COVID-19
  • Submit PR
  • Stem Cells
  • Exosomes
  • Cell Therapy
  • Cord Blood
  • Stem Cell News
  • Interviews
  • HSCs
  • iPS Cells
  • MSCs
  • Neural Stem Cells
  • Adipose SCs
  • CAR-T
  • Advertise
  • Story
  • Job Posts
Home » Products » [SALE] Global Database of Cell and Gene Therapy CMOs and CDMOs, 2022
Sale!
Cell and Gene Therapy CMOs

[SALE] Global Database of Cell and Gene Therapy CMOs and CDMOs, 2022

SKU: N/A Categories: Cell Therapy, Database Tags: cell therapy, database, gene therapy
  • Description

Description

The world’s only database of cell and gene therapy CDMOs worldwide that is publicly available. For the next 24 hours, you can claim it for an unusual 50% off.

A contract manufacturing organization (CMO) is a company that provides manufacturing services to cell and gene therapy companies on a contract basis. Contract development and manufacturing organizations (CDMOs) are similar, in that they offer services that include cell therapy product development, manufacturing, clinical trial support, and commercial supply.

Discover class-defining bioproduction tools.

Contract Manufacturing for Cell and Gene Therapies

Among cell and gene therapy companies, the pressure for manufacturing innovation and optimization can incentivize them to seek third-party partners who possess technical, manufacturing, and regulatory expertise. Benefits of partnering with a cell or gene therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. This database features companies who specialize in manufacturing and clinical trial support specifically for cell and gene therapies (CGT).

In addition to industry giants that include Lonza, Catalent​, WuXi Advanced Therapies, Minaris Regenerative Medicine, and others, there are specialty CDMOs serving the CGT marketplace. For example, FUJIFILM Cellular Dynamics opened a $21M cGMP production facility to support its internal cell therapeutics pipeline, as well as serve as a CDMO for iPS cell products. Similarly, Helixmith, a biotech company with an extensive gene therapy pipeline and a CAR-T program targeting solid tumors, expanded into CDMO services for early-stage CAR-T developers.

In other news, ThermoGenesis launched CDMO services with expertise in CAR-T cells, T cell receptor (TCR), tumor-infiltrating leukocytes (TILs), natural killer cells (NKs), iPSCs, and MSCs. Anemocyte announced itself as the first BMO (Biotech Manufacturing Organization) in the field of cell and gene therapies. In addition to building 2000 sq. metres of GMP and GMP-compliant facilities for the production of ATMP’s, its FLYn’ICE project is using drones equipped with cryogenic pods to achieve temperature controlled transit of cell and gene therapies.

Most recently, Excellos opened its doors with $15M in funding and access to one of the largest cellular material procurement portfolios yet to support cell and gene therapy manufacturing.

Of course, there have been hefty M&A deals inked within the cell and gene therapy CDMO sector as well. For example, industry behemoth Thermo Fisher Scientific snagged Brammer Bio for an astonishing $1.7 billion, while Catalent acquired Paragon Bioservices for an impressive $1.2 billion and MaSTherCell for $315 million.

Similarly, Hitachi Chemical Advanced Therapeutics Solutions (HCATS), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. Regenerative Medicine now operate under the joint name of Mineras Regenerative Medicine, while Charles River Laboratories (CRL) acquired Cognate BioServices for a hefty price tag of $875 million.

Database of Cell and Gene Therapy CMOs and CDMOs

Featuring nearly a hundred-companies worldwide, this is the world’s only database of cell and gene therapy CDMOs that is publicly available. If you are a cell therapy developer, you can use it to identify potential manufacturing partners. If you are a contract manufacturer, you can use it to identify the depth and breadth of your market competition.

The database features:

  1. Name of company
  2. City/State
  3. Country
  4. Description of cell and gene therapy manufacturing services
  5. Link to company’s CMO / CDMO services

Use it to:

1) Compare companies capable of manufacturing your cell or gene therapy product
2) Identify market competitors within the cell therapy CMO industry
3) Identify new market entrants offering CMO services
4) Spot countries with a high number of cell and gene therapy CMOs (“geographic hotspots”)

When you check out below, your product will be delivered instantly as an Excel download. Of course, your investment is backed by a Greater than 100% Money Back Guarantee.

To view License Descriptions, please click here.
For the next 24 hours, you can claim this global database for an unusual 50% off. Act fast, because this offer expires soon.

$124 – $249

Clear

Related products

  • Sale! Regenerative Medicine Database, 2022

    [NEW] Regenerative Medicine Industry Database 2022 – Featuring 1,050+ Companies

    $249 $124
    Add to cart
  • Cell and Gene Therapy Manufacturing

    The Market for Cell and Gene Therapy Manufacturing – Rise of CMOs & CDMOs

    $1,297 – $1,997
    Select options
  • Sale!

    Exosome Market Analysis: Landscape of Exosome Therapeutics & Diagnostics

    $249 $125
    Add to cart
  • Sale! Regenerative Medicine Industry Investors 2022

    Global Database of Regenerative Medicine Investors, 2022

    $197 $97
    Add to cart

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Reach BioInformant’s Audience with Your Press Announcement

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.